Dr. Ghassan Abou-Alfa wins the 2018 Blue Faery Award
Dr. Ghassan Abou-Alfa from Memorial Sloan-Kettering Cancer Center specializes in the treatment of liver cancer. Dr. Abou-Alfa serves as the chair of the National Cancer Institute (NCI) Task Force for Hepatobiliary Cancers, the chair of the AIDS Malignancy Consortium (AMC) Non-AIDS Defining Malignancies (NADC) Liver/GI Task Force and is the President-Elect for the International Society of Gastrointestinal Oncology. Dr. Abou-Alfa has lectured worldwide on the subject on liver cancer. He serves as the chair of the medical/scientific boards of Blue Faery and the Cholangiocarcinoma Foundation, and also serves on the National Medical Advisory Committee of the American Liver Foundation.
Dr. Amit Singal wins the 2017 Blue Faery Award
Dr. Amit Singal wins the 2017 Blue Faery Award for Excellence in Liver Cancer Research
Dr. Singal is an expert in Hepatocellular Carcinoma, particularly in early tumor detection and screening process failures. He serves as Clinical Chief of Hepatology and Medical Director of the Liver Tumor Program at UT Southwestern Medical Center. Dr. Singal is leading several federal and state-funded projects to evaluate interventions to improve the effectiveness of early tumor detection efforts among patients with cirrhosis. He has published several book chapters on HCC and over 100 peer-reviewed publications.
Dr. Alan Venook wins the 2016 Blue Faery Award
Dr. Alan Venook wins the 2016 Blue Faery Award for Excellence in Liver Cancer Research
As the leader of the gastrointestinal oncology clinical program and the Madden Family Distinguished Professor of Medical Oncology and Translational Research at the University of California, San Francisco, Dr. Alan Venook is a nationally recognized expert in colorectal and liver cancers. He has published more than 70 original articles, chapters or books dealing with gastrointestinal malignancies. Dr. Venook has chaired the Scientific Program for ASCO 2015 and the National Cancer Institute’s (NCI) Hepatobiliary Task Force. He is a member of NCI’s Gastrointestinal Cancer Steering Committee and currently chairs the Gastrointestinal Committee of the Alliance for Clinical Trials in Oncology, where he oversees an extensive clinical trial portfolio.